| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.92B | 21.48B | 20.76B | 18.95B | 19.04B | 19.14B |
| Gross Profit | 3.54B | 3.51B | 3.53B | 2.94B | 2.31B | 3.36B |
| EBITDA | 603.50M | 816.00M | 865.00M | 321.00M | -1.01B | -336.00M |
| Net Income | -240.00M | -593.00M | -60.00M | -497.00M | -1.81B | -1.82B |
Balance Sheet | ||||||
| Total Assets | 32.20B | 31.21B | 32.01B | 33.04B | 33.86B | 32.64B |
| Cash, Cash Equivalents and Short-Term Investments | 2.81B | 3.08B | 2.72B | 3.46B | 4.47B | 2.72B |
| Total Debt | 5.13B | 5.10B | 5.03B | 5.75B | 6.21B | 3.57B |
| Total Liabilities | 17.64B | 16.98B | 17.39B | 18.83B | 19.47B | 16.47B |
| Stockholders Equity | 13.55B | 13.10B | 13.60B | 13.27B | 13.50B | 15.30B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 558.00M | -563.00M | -343.00M | -1.03B | -811.00M |
| Operating Cash Flow | 0.00 | 919.00M | -30.00M | 53.00M | -536.00M | 150.00M |
| Investing Cash Flow | 0.00 | -419.00M | -362.00M | -321.00M | -113.00M | -979.00M |
| Financing Cash Flow | 0.00 | -158.00M | -367.00M | -761.00M | 2.39B | 196.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥5.65B | 9.12 | ― | 1.39% | 3.01% | 37.62% | |
69 Neutral | ¥2.40T | 11.00 | 11.64% | 1.52% | 11.97% | 45.59% | |
63 Neutral | ¥395.07B | 13.04 | 13.71% | 3.38% | 0.16% | -12.55% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥6.47B | 9.15 | ― | 3.50% | -1.92% | -2.68% | |
52 Neutral | ¥35.55B | 20.68 | ― | 3.70% | 29.30% | -82.16% | |
48 Neutral | ¥4.32B | -7.17 | ― | ― | 3.48% | -822.25% |